Preparation and in vitro evaluation of analgesic microemulsion cataplasm

Ye-wen ZHANG,Qiong WANG,Jing-xin YU,Hui LI,Qian KANG,Qing ZHANG,Peng TAN,Qing WU
DOI: https://doi.org/10.3969/j.issn.1006-2157.2015.04.008
2015-01-01
Abstract:Objective To investigate the influence of microemulsion technology on release capability and transdermal permeability of components in cataplasm. Methods With the initial bonding strength, 180 degree force strength and sensory evaluation scores as indicators, the formula of the analgesic microemul-sion cataplasm matrix was optimized by using single factor experiment combined with central composite de-sign-response surface design methodology. Modified Franz diffusion cell was used to compare the release capability and transdermal permeability between analgesic microemulsion cataplasm ( MEC) and analgesic common cataplasm ( CC) with indicators of ferulic acid and imperatorin. Results Optimized matrix formu-la was NP700, carbomer 941, carbomer 934, aluminum compounds, tartaric acid and glycerin with the rati-o of 1∶0. 1∶0. 25∶0. 04∶0. 04∶6 . The release capability in vitro of ferulic acid and imperatorin in MEC and CC conformed to zero-order kinetic equation with a dual mechanism of diffusion and dissolution. The stead-y-state permeation rate of ferulic acid in MEC was 1. 92 μg/( h·cm2 ) and that in CC was 0. 97 μg/( h· cm2);that of imperatorin in MEC was 0. 28 μg/(h·cm2), while in CC was 0. 09 μg/(h·cm2). Com-pared with CC, the cumulative release rate of effective components multiplied. Conclusion Microemul-sion technology can significantly promote the transdermal permeability of components in cataplasm.
What problem does this paper attempt to address?